Schizoaffective Disorders Completed Phase 4 Trials for Omega-3-acid ethyl esters (DB09539)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00833976Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated HypertriglyceridemiaTreatment